How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any aspects of the recommendations that need particular consideration to ensure we avoid unlawful discrimination against any group of people on the grounds of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex or sexual orientation?
The content on this page is not current guidance and is only for the purposes of the consultation process.

2 Information about linzagolix

Marketing authorisation indication

2.1

Linzagolix (Yselty, Theramex) is indicated for the 'treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age'.

Price

2.3

The list price of linzagolix is £99 for a 28 pack of 100 mg or 200 mg tablets. The cost for an 84 pack of estradiol and norethisterone tablets known as hormonal add-back therapy (ABT) is £13.20. At list price, 12 months of treatment would cost £1,287 (without ABT) and £1,353 (with ABT).

2.4

The company has a commercial arrangement This makes linzagolix available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of this discount.